SU5416 in Treating Children With Recurrent or Progressive Brain Tumors

This study has been terminated.

(The pharmaceutical company discontinued further development of SU5416.)

Sponsor:

Collaborator:

Information provided by:

Pediatric Brain Tumor Consortium

ClinicalTrials.gov Identifier:

NCT00006247

First received: September 11, 2000

Last updated: October 13, 2009

Last verified: October 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	March 2006
Primary Completion Date:	July 2003 (Final data collection date for primary outcome measure)

Publications: